Pages
Home
Our Purpose
Leadership
Other Links
Thursday, December 16, 2010
Novartis Europharm Ltd. Withdraws Its Application For An Extension Of Indication For Zometa (zoledronic Acid)
Novartis Europharm Ltd. Withdraws Its Application For An Extension Of Indication For Zometa (zoledronic Acid)
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment